Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03331796 · ClinicalTrials.gov registry record · NA

Noninvasive Brain Stimulation for Mild Cognitive Impairment

A NA study of Mild Cognitive Impairment and Cognitive Decline, sponsored by Palo Alto Veterans Institute for Research.

Completed
Registry status
NA
Development phase
69
Enrollment target
1
Study location

NCT03331796 is a NA study of Mild Cognitive Impairment and Cognitive Decline that has completed, run by Palo Alto Veterans Institute for Research. The registered enrollment target is 69 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03331796, a NA study of Mild Cognitive Impairment and Cognitive Decline, has completed, sponsored by Palo Alto Veterans Institute for Research.

COMPLETED
Registry status
NA
Development phase
69 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to test the efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) as a treatment for Mild Cognitive Impairment (MCI). Participants will be randomly assigned to one of three treatment groups: Group 1: Active Dorsolateral Prefrontal Cortex (DLPFC) rTMS; Group 2: Active Lateral Parietal Cortex (LPC) rTMS; and Group 3: Inactive rTMS (Placebo) control (evenly split between each coil location). Participation in the study takes approximately 7 ½ months-including a 2-to 4-week treatment phase (20 rTMS sessions) and a 6-month follow-up phase.

Conditions Studied

Mild Cognitive Impairment Cognitive Decline Cognitive Dysfunction Memory Impairment Memory Loss Memory Decline Mild Neurocognitive Disorder Mental Deterioration

Interventions

  • DEVICE Active rTMS (Bilateral DLPFC)
  • DEVICE Active rTMS (Bilateral LPC)
  • DEVICE Placebo rTMS (Inactive)

Study Locations (1)

California

  • VA Palo Alto Health Care System - Palo Alto

Trial Details

FieldValue
Enrollment Target 69 participants
Start Date 2018-06-15
Est. Completion 2023-03-28
Phase NA

Sponsor

Palo Alto Veterans Institute for Research

35 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03331796

The ClinicalTrials.gov registry entry for NCT03331796 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (95% lower). The listed sponsor is Palo Alto Veterans Institute for Research, which has 35 total studies on file at ClinicalTrials.gov.

The record links to 8 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 3 interventions - of which Active rTMS (Bilateral DLPFC) is the first listed.

NCT03331796 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03331796 about?

NCT03331796 is a clinical study titled "Noninvasive Brain Stimulation for Mild Cognitive Impairment". The goal of this study is to test the efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) as a treatment for Mild Cognitive Impairment (MCI). Participants will be randomly assigned to one of three treatment groups: Group 1: Active Dorsolateral Prefrontal Cortex (DLPFC) rTMS; Group 2: Act...

What is the current status of trial NCT03331796?

This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2018-06-15. Estimated completion is 2023-03-28.

What conditions does trial NCT03331796 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment, Cognitive Decline, Cognitive Dysfunction, Memory Impairment, Memory Loss.

What interventions are being tested in trial NCT03331796?

The interventions under investigation include: Active rTMS (Bilateral DLPFC) (DEVICE), Active rTMS (Bilateral LPC) (DEVICE), Placebo rTMS (Inactive) (DEVICE).

Who is sponsoring clinical trial NCT03331796?

This trial is sponsored by Palo Alto Veterans Institute for Research, which has 35 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03331796 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Mild Cognitive Impairment

All registered trials for this condition

Cognitive Decline

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.